Q32 Bio, Inc. (QTTB)
8.72
-0.10
(-1.13%)
USD |
NASDAQ |
Nov 13, 16:00
8.72
0.00 (0.00%)
After-Hours: 19:59
Q32 Bio Price : 8.72 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 9.15 | 9.23 | 8.53 | 8.82 | 355593.0 |
| Nov 11, 2026 | 9.39 | 9.44 | 9.12 | 9.20 | 236260.0 |
| Nov 10, 2026 | 9.21 | 9.74 | 9.21 | 9.33 | 324635.0 |
| Nov 09, 2026 | 9.35 | 9.65 | 9.00 | 9.34 | 413338.0 |
| Nov 06, 2026 | 8.83 | 9.36 | 8.83 | 9.25 | 214764.0 |
| Nov 05, 2026 | 8.91 | 8.93 | 8.225 | 8.85 | 583407.0 |
| Nov 04, 2026 | 8.865 | 9.17 | 8.51 | 8.97 | 220744.0 |
| Nov 03, 2026 | 8.68 | 9.035 | 8.68 | 8.76 | 175211.0 |
| Nov 02, 2026 | 8.89 | 9.00 | 8.545 | 8.71 | 246693.0 |
| Oct 30, 2026 | 8.87 | 8.98 | 8.52 | 8.91 | 268179.0 |
| Oct 29, 2026 | 9.20 | 9.349 | 8.86 | 8.87 | 317922.0 |
| Oct 28, 2026 | 8.65 | 9.11 | 8.51 | 9.06 | 409360.0 |
| Oct 27, 2026 | 8.52 | 8.82 | 8.428 | 8.71 | 692682.0 |
| Oct 26, 2026 | 8.60 | 8.825 | 8.39 | 8.45 | 563885.0 |
| Oct 23, 2026 | 8.80 | 8.835 | 8.30 | 8.65 | 404053.0 |
| Oct 22, 2026 | 8.67 | 9.01 | 8.60 | 8.80 | 363639.0 |
| Oct 21, 2026 | 8.62 | 8.81 | 8.55 | 8.67 | 322326.0 |
| Oct 20, 2026 | 7.79 | 8.84 | 7.79 | 8.62 | 506472.0 |
| Oct 19, 2026 | 7.52 | 7.94 | 7.52 | 7.79 | 609940.0 |
| Oct 16, 2026 | 7.82 | 7.82 | 7.28 | 7.52 | 678979.0 |
| Oct 15, 2026 | 8.01 | 8.29 | 7.72 | 7.77 | 625386.0 |
| Oct 14, 2026 | 7.93 | 8.30 | 7.72 | 8.01 | 889541.0 |
| Oct 13, 2026 | 8.69 | 8.69 | 7.89 | 8.06 | 719979.0 |
| Oct 12, 2026 | 8.64 | 9.155 | 8.44 | 8.74 | 684593.0 |
| Oct 09, 2026 | 8.125 | 8.46 | 7.94 | 8.34 | 854920.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Intellia Therapeutics, Inc. | 9.705 |
| Beam Therapeutics, Inc. | 22.85 |
| Prime Medicine, Inc. | 4.255 |
| Korsana Biosciences, Inc. | 31.58 |
| Prelude Therapeutics, Inc. | 3.45 |
Price Related Metrics
| PE Ratio | 2.609 |
| PS Ratio | 3.288 |
| Price to Book Value | 0.9061 |
| Earnings Yield | 38.33% |
| Market Cap | 260.66M |
| Operating PE Ratio | 9.614 |
| Normalized PE Ratio | 2.605 |